Basic Information
ID: ALA5039235
Type: Functional
Description: Antiviral activity against Human coxsackievirus B3 infected in Vero cells assessed as reduction in plaque formation treated 2 hrs post viral infection and measured 3 to 4 days post-infection by Giemsa staining based plaque reduction assay
Organism: Coxsackievirus B3
Cell type: Vero
Activity Charts
Bioactivity
Activity Types for Assay ALA5039235
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 433.51 | 1.64 | 1.64 |
| 446.51 | 1.72 | 1.72 |
| 489.57 | 2.17 | 2.17 |
| 545.64 | 1.86 | 1.86 |